Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3307 results

Sort By:

Virtual Reality for Shoulder Rehabilitation

Study ID: NCT06797492
Start Date: 2025-09
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Shoulder Physical Examination

Shoulder Rehabilitation in a Virtual Environment

Usability assessment and presence and co-presence evaluation

Sponsor

BIO-Medical Polyclinic University Polyclinic Foundation

Source: clinicaltrials.gov

Share:
Add to list

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Study ID: NCT06538389
Start Date: 2025-08-15
End Date: 2026-08-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Biospecimen Collection

BRC-001

Placebo Administration

Administration questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Pentoxifylline for Vascular Calcification in Kidney Disease

Study ID: NCT06903689
Start Date: 2025-04-15
End Date: 2025-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Pentoxifylline 400 MG Oral Tablet

Conventional Medications for Chronic Kidney Disease

Sponsor

Mansoura University

Source: clinicaltrials.gov

Share:
Add to list

Mapping Snakebite Risk in Ghana and Rwanda

Study ID: NCT06808789
Start Date: 2025-05
End Date: 2026-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

32000

Intervention / Treatment
Sponsor

Liverpool School of Tropical Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study ID: NCT06839872
Start Date: 2025-06-30
End Date: 2030-07-29
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Pester

Acalabrutib

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Study ID: NCT06841172
Start Date: 2025-04-15
End Date: 2028-03-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

132

Intervention / Treatment

radiotherapy

Systemic therapy (Continuation of current first-line systemic therapy)

Systemic therapy (Early switch to second-line systemic therapy)

Sponsor

Shandong Cancer Hospital and Institute

Source: clinicaltrials.gov

Share:
Add to list

Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum

Study ID: NCT05422469
Start Date: 2025-08
End Date: 2029-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Medtronic Percept RC neurostimulator

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Spica Cast Duration for DDH

Study ID: NCT06204068
Start Date: 2025-05
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Spica cast

Rhino brace

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM

Study ID: NCT06822972
Start Date: 2025-05-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Selinexor 40 mg

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Self-harm and the Prison Environment Mixed Methods Study

Study ID: NCT06895668
Start Date: 2025-07-01
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

458

Intervention / Treatment

None (cohort study)

Sponsor

King's College London

Source: clinicaltrials.gov

Share:
Add to list